BriaCell reports influx of cancer fighting CD8+ “killer” T cell into metastatic breast cancer tumors and lymph organs turning ...

The problem of cell phones in school has perplexed Chad Brinkman since he became principal of Delphos-Jefferson High School ...

I would cautiously say that the mortality rate for newborns diagnosed with sickle cell at birth is decreasing.

Therapeutics highlights the infiltration of cancer fighting immune cells into tumors, using leading CD8 ImmunoPET imaging ...

This pair of posters presented at the 66th American Society of Hematology Annual Meeting & Exposition provides updates on ...

Median overall survival (OS) to date of 13.4 months for Phase 2 patients treated with the Phase 3 formulation (15.6 months for those treated ...

The company highlighted some preclinical data supporting human studies in a poster presented at the ACR Convergence. The ...

Be Biopharma, Inc. ("Be Bio"), a clinical-stage company pioneering engineered B Cell Medicines (BCMs), today announced two key updates at the 66th ASH Annual Meeting in San Diego, CA. These updates ...

University of Cincinnati Cancer Center experts will present abstracts at the 66th American Society of Hematology (ASH) Annual ...

In a meta-analysis, second-generation BTK inhibitors were linked to a significantly low incidence of atrial fibrillation, ...

Researchers at the meeting reported on long-term activity of commercialized gene therapies and preliminary data on ...

Dec. 11, 2024 — Gut microbiome composition during pregnancy has long-term effects on offspring stem cell growth and development, researchers report. Treating pregnant mice with a common gut ...